MCID: CHL026
MIFTS: 16

Childhood Ovarian Embryonal Carcinoma

Categories: Cancer diseases, Fetal diseases

Aliases & Classifications for Childhood Ovarian Embryonal Carcinoma

MalaCards integrated aliases for Childhood Ovarian Embryonal Carcinoma:

Name: Childhood Ovarian Embryonal Carcinoma 12 69
Childhood Embryonal Carcinoma of the Ovary 12
Pediatric Embryonal Carcinoma of Ovary 12

Classifications:



External Ids:

Disease Ontology 12 DOID:8036
NCIt 47 C6546
UMLS 69 C1332989

Summaries for Childhood Ovarian Embryonal Carcinoma

Disease Ontology : 12 An ovarian embryonal carcinoma that occurs in childhood.

MalaCards based summary : Childhood Ovarian Embryonal Carcinoma, is also known as childhood embryonal carcinoma of the ovary, and has symptoms including abdominal pain The drugs Amphotericin B and Miconazole have been mentioned in the context of this disorder. Affiliated tissues include ovary, bone marrow and bone.

Related Diseases for Childhood Ovarian Embryonal Carcinoma

Symptoms & Phenotypes for Childhood Ovarian Embryonal Carcinoma

UMLS symptoms related to Childhood Ovarian Embryonal Carcinoma:


abdominal pain

Drugs & Therapeutics for Childhood Ovarian Embryonal Carcinoma

Drugs for Childhood Ovarian Embryonal Carcinoma (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 72)
id Name Status Phase Clinical Trials Cas Number PubChem Id
1
Amphotericin B Approved, Investigational Phase 3 1397-89-3 14956 5280965
2
Miconazole Approved, Investigational, Vet_approved Phase 3 22916-47-8 4189
3
Palivizumab Approved, Investigational Phase 3 188039-54-5
4
Ribavirin Approved Phase 3 36791-04-5 37542
5
Fluconazole Approved Phase 3 86386-73-4 3365
6
Itraconazole Approved, Investigational Phase 3 84625-61-6 55283
7
Captopril Approved Phase 3 62571-86-2 44093
8
Cyclophosphamide Approved, Investigational Phase 3 50-18-0, 6055-19-2 2907
9
Caspofungin Approved Phase 3 179463-17-3, 162808-62-0 468682 2826718
10
Carboplatin Approved Phase 3,Phase 2 41575-94-4 10339178 498142 38904
11
Bleomycin Approved Phase 3 11056-06-7 5360373
12
Cisplatin Approved Phase 3 15663-27-1 84093 441203 2767
13
Etoposide Approved Phase 3,Phase 2 33419-42-0 36462
14 Anti-Bacterial Agents Phase 3
15 Antifungal Agents Phase 3
16 Anti-Infective Agents Phase 3,Phase 2
17 Antiparasitic Agents Phase 3
18 Antiprotozoal Agents Phase 3
19 Liposomal amphotericin B Phase 3
20 Antibodies Phase 3,Phase 1
21 Antibodies, Monoclonal Phase 3,Phase 1
22 Antimetabolites Phase 3
23 Antiviral Agents Phase 3,Phase 2
24 Immunoglobulins Phase 3,Phase 1
25 Cytochrome P-450 CYP2C9 Inhibitors Phase 3
26 Cytochrome P-450 CYP3A Inhibitors Phase 3
27 Cytochrome P-450 Enzyme Inhibitors Phase 3
28 Hormone Antagonists Phase 3,Phase 1,Phase 2
29 Hormones Phase 3,Phase 1,Phase 2
30 Hormones, Hormone Substitutes, and Hormone Antagonists Phase 3,Phase 1,Phase 2
31 Hydroxyitraconazole Phase 3
32 Steroid Synthesis Inhibitors Phase 3
33 Alkylating Agents Phase 3,Phase 2
34 Angiotensin-Converting Enzyme Inhibitors Phase 3
35 Antihypertensive Agents Phase 3
36 Antirheumatic Agents Phase 3
37 HIV Protease Inhibitors Phase 3
38 Immunosuppressive Agents Phase 3,Phase 1,Phase 2
39
protease inhibitors Phase 3
40 Echinocandins Phase 3
41 Antimitotic Agents Phase 3,Phase 2
42 Antineoplastic Agents, Phytogenic Phase 3,Phase 2
43 Antibiotics, Antitubercular Phase 3
44 Dermatologic Agents Phase 3
45 Etoposide phosphate Phase 3,Phase 2
46 Keratolytic Agents Phase 3
47 Podophyllotoxin Phase 3 518-28-5
48 Topoisomerase Inhibitors Phase 3,Phase 2
49
Ifosfamide Approved Phase 2 3778-73-2 3690
50
Lenograstim Approved Phase 2 135968-09-1

Interventional clinical trials:

(show all 17)

id Name Status NCT ID Phase Drugs
1 Liposomal Amphotericin B in Treating Granulocytopenia and Persistent Unexplained Fever in Cancer Patients Completed NCT00003938 Phase 3 liposomal amphotericin B
2 Ribavirin With or Without Monoclonal Antibody Therapy in Treating Patients Who Develop RSV Pneumonia Following Peripheral Stem Cell Transplantation Completed NCT00014391 Phase 3 ribavirin
3 Itraconazole Compared With Fluconazole to Prevent Infections in Patients Undergoing Peripheral Stem Cell or Bone Marrow Transplantation Completed NCT00003883 Phase 3 fluconazole;itraconazole
4 Captopril in Treating Patients Undergoing Bone Marrow or Stem Cell Transplantation Completed NCT00004230 Phase 3 captopril;cyclophosphamide
5 Caspofungin Acetate Compared With Amphotericin B Liposomal in Treating Patients With Persistent Fever and Neutropenia Following Cancer Treatment Completed NCT00008359 Phase 3 caspofungin acetate;liposomal amphotericin B
6 Active Surveillance, Bleomycin, Carboplatin, Etoposide, or Cisplatin in Treating Pediatric and Adult Patients With Germ Cell Tumors Recruiting NCT03067181 Phase 3 Bleomycin;Carboplatin;Cisplatin;Etoposide
7 Surgery and Combination Chemotherapy in Treating Children With Extracranial Germ Cell Tumors Active, not recruiting NCT00053352 Phase 3 cisplatin;etoposide
8 Combination Chemotherapy in Treating Young Patients With Recurrent or Resistant Malignant Germ Cell Tumors Completed NCT00467051 Phase 2 paclitaxel;carboplatin;ifosfamide
9 Biological Therapy Following Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Cancer Completed NCT00003408 Phase 2
10 Lymphocyte Infusion in Treating Patients With Relapsed Cancer After Bone Marrow or Peripheral Stem Cell Transplantation Completed NCT00003887 Phase 2
11 Beclomethasone in Treating Patients With Graft-Versus-Host Disease of the Esophagus, Stomach, Small Intestine, or Colon Completed NCT00010283 Phase 1, Phase 2 beclomethasone dipropionate
12 Interleukin-11 Plus Filgrastim Prior to Peripheral Stem Cell Transplantation in Patients With Non-Hodgkin's Lymphoma, Hodgkin's Disease, Breast Cancer, or Other Solid Tumors Completed NCT00004157 Phase 2
13 Immunotherapy in Treating Patients Who Are Undergoing Bone Marrow or Peripheral Stem Cell Transplantation Completed NCT00002673 Phase 2
14 Autologous Peripheral Blood Stem Cell Transplant for Germ Cell Tumors Recruiting NCT00432094 Phase 2 carboplatin;etoposide;ifosfamide;paclitaxel;thiotepa;Mesna
15 Ipilimumab After Allogeneic Stem Cell Transplant in Treating Patients With Persistent or Progressive Cancer Completed NCT00060372 Phase 1 ipilimumab;therapeutic allogeneic lymphocytes
16 Interleukin-12 in Treating Patients With Hematologic Cancers or Solid Tumors Completed NCT00003107 Phase 1
17 DNA Analysis in Samples From Younger Patients With Germ Cell Tumors and Their Parents or Siblings Recruiting NCT01434355

Search NIH Clinical Center for Childhood Ovarian Embryonal Carcinoma

Genetic Tests for Childhood Ovarian Embryonal Carcinoma

Anatomical Context for Childhood Ovarian Embryonal Carcinoma

MalaCards organs/tissues related to Childhood Ovarian Embryonal Carcinoma:

39
Ovary, Bone Marrow, Bone, Breast, Colon, Small Intestine

Publications for Childhood Ovarian Embryonal Carcinoma

Variations for Childhood Ovarian Embryonal Carcinoma

Expression for Childhood Ovarian Embryonal Carcinoma

Search GEO for disease gene expression data for Childhood Ovarian Embryonal Carcinoma.

Pathways for Childhood Ovarian Embryonal Carcinoma

GO Terms for Childhood Ovarian Embryonal Carcinoma

Sources for Childhood Ovarian Embryonal Carcinoma

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
16 ExPASy
18 FMA
28 GO
29 GTR
30 HGMD
31 HMDB
32 HPO
33 ICD10
34 ICD10 via Orphanet
35 ICD9CM
36 IUPHAR
37 KEGG
38 LifeMap
40 MedGen
42 MeSH
43 MESH via Orphanet
44 MGI
46 NCI
47 NCIt
48 NDF-RT
51 NINDS
52 Novoseek
54 OMIM
55 OMIM via Orphanet
59 PubMed
60 QIAGEN
65 SNOMED-CT via HPO
66 SNOMED-CT via Orphanet
67 TGDB
68 Tocris
69 UMLS
70 UMLS via Orphanet
Content
Loading form....